Antimicrobial resistance in bacterial sexually transmitted infections

  30 March 2026

Antimicrobial resistance (AMR) is becoming a serious threat in sexually transmitted infections (STIs), particularly for Neisseria gonorrhoeae and Mycoplasma genitalium, which are increasingly resistant to all available treatments—raising concerns they could become untreatable.

  • Treatment failures are already being reported for these infections
  • Treponema pallidum (syphilis) shows emerging resistance to macrolides
  • Chlamydia trachomatis remains treatable, but resistance could develop

Without urgent action—including better surveillance, responsible antibiotic use, improved diagnostics, and development of new drugs and vaccines—common STIs could become much harder or even impossible to treat.

Further reading: Medicine
Author(s): Rachel Pitt-Kendall, Helen Fifer
Effective Surveillance  
Back

OUR UNDERWRITERS

Unrestricted financial support by:

Antimicrobial Resistance Fighter Coalition

INTERNATIONAL FEDERATION PHARMACEUTICAL MANUFACTURERS & ASSOCIATIONS

BD





AMR NEWS

Your Biweekly Source for Global AMR Insights!

Stay informed with the essential newsletter that brings together all the latest One Health news on antimicrobial resistance. Delivered straight to your inbox every two weeks, AMR NEWS provides a curated selection of international insights, key publications, and the latest updates in the fight against AMR.

Don’t miss out on staying ahead in the global AMR movement—subscribe now!

Subscribe
What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!